ESPR - Esperion Therapeutics, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Annual

Balance Sheet

All numbers in thousands
Breakdown
12/30/2018
12/30/2017
12/30/2016
12/30/2015
Assets
Current Assets
Cash
Cash And Cash Equivalents
36,973
34,468
38,165
77,336
Short Term Investments
99,050
165,731
173,418
134,925
Total Cash
36,973
34,468
38,165
77,336
Net Receivables
-
-
-
-
Inventory
-
-
-
-
Other Current Assets
-
0
0
0
Total Current Assets
142,632
203,924
213,577
214,394
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
1,516
1,279
1,281
1,162
Accumulated Depreciation
-996
-844
-607
-355
Net property, plant and equipment
520
435
674
807
Equity and other investments
99,293
239,151
204,324
215,240
Goodwill
-
-
-
-
Intangible Assets
56
56
56
56
Other long-term assets
-
0
0
0
Total non-current assets
819
73,911
31,636
81,178
Total Assets
143,451
277,835
245,213
295,572
Liabilities and stockholders' equity
Liabilities
Current Liabilities
Total Revenue
-
1,045
1,709
1,604
Accounts Payable
44,893
20,375
4,595
707
Taxes payable
-
-
-
-
Accrued liabilities
17,563
11,104
8,789
2,706
Deferred revenues
-
-
-
-
Other Current Liabilities
-
0
0
0
Total Current Liabilities
64,333
33,144
15,589
5,625
Non-current liabilities
Long Term Debt
-
0
1,022
2,688
Deferred taxes liabilities
-
-
-
-
Deferred revenues
-
-
-
-
Other long-term liabilities
-
-
0
0
Total non-current liabilities
0
0
1,022
2,688
Total Liabilities
64,333
33,144
16,611
8,313
Stockholders' Equity
Common Stock
27
26
23
23
Retained Earnings
-598,101
-396,291
-229,200
-154,222
Accumulated other comprehensive income
-319
-845
-172
-482
Total stockholders' equity
-598,101
-396,291
-229,200
-154,222
Total liabilities and stockholders' equity
143,451
277,835
245,213
295,572